skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: language: Chinese remove Database: Wiley-Blackwell Open Access Titles remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non‐small cell lung cancer after two lines of chemotherapy
China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non‐small cell lung cancer after two lines of chemotherapy
Material Type:
Article 		Add to My Research

China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non‐small cell lung cancer after two lines of chemotherapy

Cancer communications (London, England), 2019-06, Vol.39 (1), p.1-10 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0383-7 ;PMID: 31221221

Full text available

Citations Cited by
2
Two hits to the renin‐angiotensin system may play a key role in severe COVID‐19
Two hits to the renin‐angiotensin system may play a key role in severe COVID‐19
Material Type:
Article 		Add to My Research

Two hits to the renin‐angiotensin system may play a key role in severe COVID‐19

The Kaohsiung journal of medical sciences, 2020-06, Vol.36 (6), p.389-392 [Peer Reviewed Journal]

2020 The Authors. published by John Wiley & Sons Australia on behalf of Kaohsiung Medical University. ;2020 The Authors. The Kaohsiung Journal of Medical Sciences published by John Wiley & Sons Australia on behalf of Kaohsiung Medical University. ;COPYRIGHT 2020 John Wiley & Sons, Inc. ;2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1607-551X ;EISSN: 2410-8650 ;DOI: 10.1002/kjm2.12237 ;PMID: 32492292

Full text available

Citations Cited by
3
Endoscopic treatment of hypertensive intracerebral hemorrhage:A technical review
Endoscopic treatment of hypertensive intracerebral hemorrhage:A technical review
Material Type:
Article 		Add to My Research

Endoscopic treatment of hypertensive intracerebral hemorrhage:A technical review

Chronic diseases and translational medicine, 2016-09, Vol.2 (3), p.140-146 [Peer Reviewed Journal]

2016 Chinese Medical Association ;2016 The Authors. Chronic Diseases and Translational Medicine published by John Wiley & Sons, Ltd on behalf of Chinese Medical Association ;Copyright © Wanfang Data Co. Ltd. All Rights Reserved. ;2016 Chinese Medical Association. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. 2016 Chinese Medical Association ;ISSN: 2095-882X ;ISSN: 2589-0514 ;EISSN: 2589-0514 ;DOI: 10.1016/j.cdtm.2016.11.002 ;PMID: 29063035

Full text available

Citations Cited by
4
Review of the present features and the infection control challenges of COVID‐19 pandemic in dialysis facilities
Review of the present features and the infection control challenges of COVID‐19 pandemic in dialysis facilities
Material Type:
Article 		Add to My Research

Review of the present features and the infection control challenges of COVID‐19 pandemic in dialysis facilities

The Kaohsiung journal of medical sciences, 2020-06, Vol.36 (6), p.393-398 [Peer Reviewed Journal]

2020 The Authors. published by John Wiley & Sons Australia on behalf of Kaohsiung Medical University. ;2020 The Authors. The Kaohsiung Journal of Medical Sciences published by John Wiley & Sons Australia on behalf of Kaohsiung Medical University. ;COPYRIGHT 2020 John Wiley & Sons, Inc. ;2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1607-551X ;EISSN: 2410-8650 ;DOI: 10.1002/kjm2.12239 ;PMID: 32492290

Full text available

Citations Cited by
5
Diabetes care during the outbreak of 2019 novel coronavirus disease (COVID‐19) in Taiwan
Diabetes care during the outbreak of 2019 novel coronavirus disease (COVID‐19) in Taiwan
Material Type:
Article 		Add to My Research

Diabetes care during the outbreak of 2019 novel coronavirus disease (COVID‐19) in Taiwan

The Kaohsiung journal of medical sciences, 2020-08, Vol.36 (8), p.658-659 [Peer Reviewed Journal]

2020 The Authors. published by John Wiley & Sons Australia on behalf of Kaohsiung Medical University. ;COPYRIGHT 2020 John Wiley & Sons, Inc. ;2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1607-551X ;EISSN: 2410-8650 ;DOI: 10.1002/kjm2.12257

Full text available

Citations Cited by
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait